Patients who receive an add-on medication soon after a heart attack have a significantly better prognosis than those who receive it later, or not all.
This is according to a new study from researchers at Lund University in Sweden and Imperial College London. The findings suggest that treating patients earlier with a combination of statins and the cholesterol-lowering drug ezetimibe could prevent thousands of new heart attacks over a decade.
Cardiovascular disease is by far the most common…
Continue Reading
News Source: www.sciencedaily.com
Leave a Reply